After slow start, project to channel drug company funds to universities builds steam.
Drug companies appear to have been listening when researchers began complaining about their lack of participation in the MRC/PMAC Health Program, for the 30-month-old project appears to have taken on new life. It is designed to increase collaboration between university and pharmaceutical industry researchers by directing more of the industry's growing investment in Canada through the MRC's peer-review process. By mid-May, program commitments stood at $60 million.
Berkowitz
P
P
D002170:Canada; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D007373:Interinstitutional Relations; D017712:Peer Review, Research; D012109:Research Support as Topic / Q000458:organization & administration*; D014495:Universities / Q000458:organization & administration*